Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Código da empresaHBIO
Nome da EmpresaHarvard Bioscience Inc
Data de listagemOct 21, 2013
CEOMr. John D. Duke
Número de funcionários330
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 21
Endereço84 October Hill Rd
CidadeHOLLISTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal01746-1371
Telefone15088938999
Sitehttps://www.harvardbioscience.com/
Código da empresaHBIO
Data de listagemOct 21, 2013
CEOMr. John D. Duke
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados